{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:00:12Z","timestamp":1772157612645,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018719","name":"University of Missouri School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017834","name":"UConn Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omton.2025.201080","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:20:41Z","timestamp":1761960041000},"page":"201080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Nan","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-4876","authenticated-orcid":false,"given":"Olamide T.","family":"Olaoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harinarayanan","family":"Janakiraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest Ramsay","family":"Camp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric T.","family":"Kimchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin F.","family":"Staveley-O\u2019Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-568X","authenticated-orcid":false,"given":"Guangfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201080_bib1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1001\/jama.2021.20068","article-title":"A Review of Pancreatic Cancer-Reply","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.omton.2025.201080_bib2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201080_bib3","first-page":"220","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2025.201080_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omton.2025.201080_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccr.2014.05.026","article-title":"Pancreatic cancer stroma: friend or foe?","volume":"25","author":"Gore","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib6","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2025.201080_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2015.09.020","article-title":"Subtyping Pancreatic Cancer","volume":"28","author":"Biankin","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","article-title":"Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer","volume":"31","author":"Halbrook","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Mucciolo","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccell.2020.02.010","article-title":"Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance","volume":"37","author":"Bednar","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccell.2017.02.014","article-title":"Pancreatic Cancer Genomics 2.0: Profiling Metastases","volume":"31","author":"Collisson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/2159-8290.CD-23-1480","article-title":"Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches","volume":"15","author":"Xu","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101138","article-title":"MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability","volume":"61","author":"Ephraums","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.omton.2025.201080_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omton.2025.201080_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ccell.2023.04.001","article-title":"Simultaneous targeting of PD-1 and IL-2R\u03b2\u03b3 with radiation therapy inhibits pancreatic cancer growth and metastasis","volume":"41","author":"Piper","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib16","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3748\/wjg.v21.i11.3157","article-title":"Update on the management of pancreatic cancer: surgery is not enough","volume":"21","author":"Ansari","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omton.2025.201080_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","article-title":"MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccell.2020.09.012","article-title":"CDK4\/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma","volume":"38","author":"Salvador-Barbero","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s43018-022-00349-2","article-title":"Translational advances in pancreatic ductal adenocarcinoma therapy","volume":"3","author":"Hosein","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2025.201080_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and Opportunities for Pancreatic Cancer Immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2407-14-75","article-title":"Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2025.201080_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba9772","article-title":"Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models","volume":"13","author":"Lin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2025.201080_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12935-021-01776-4","article-title":"Adeno-associated virus (AAV)-based gene therapy for glioblastoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.omton.2025.201080_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omton.2025.201080_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ccell.2021.07.013","article-title":"Is resistance to targeted therapy in cancer inevitable?","volume":"39","author":"Smith","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib26","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/2159-8290.CD-23-1323","article-title":"A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1\u03b1 Nuclear Retention","volume":"14","author":"Yamaguchi","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4251\/wjgo.v8.i1.55","article-title":"State of the art biological therapies in pancreatic cancer","volume":"8","author":"Di Marco","year":"2016","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.omton.2025.201080_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10020036","article-title":"Targeted Therapies for Pancreatic Cancer","volume":"10","author":"Amanam","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201080_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2004.08.030","article-title":"Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis","volume":"6","author":"Chen","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood.V91.2.603","article-title":"Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation","volume":"91","author":"Chen","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201080_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1097-2765(03)00341-1","article-title":"BTB\/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases","volume":"12","author":"Geyer","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2025.201080_bib32","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/sj.onc.1204608","article-title":"Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway","volume":"20","author":"Unoki","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.201080_bib33","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.febslet.2013.09.020","article-title":"Ankyrin repeat and BTB\/POZ domain containing protein-2 inhibits the aggregation of alpha-synuclein: implications for Parkinson's disease","volume":"587","author":"Roy","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2025.201080_bib34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/0008-5472.CAN-09-2249","article-title":"ZNF238 Is Expressed in Postmitotic Brain Cells and Inhibits Brain Tumor Growth","volume":"70","author":"Tatard","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201080_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13148-020-00867-9","article-title":"BTB\/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6\/ZBTB27","volume":"12","author":"He","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.omton.2025.201080_bib36","doi-asserted-by":"crossref","first-page":"18739","DOI":"10.1073\/pnas.0604083103","article-title":"A BTB\/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival","volume":"103","author":"Nakayama","year":"2006","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.omton.2025.201080_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.571517","article-title":"ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer","volume":"10","author":"Gong","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201080_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051163","article-title":"Preliminary Study on the Sequencing of Whole Genomic Methylation and Transcriptome-Related Genes in Thyroid Carcinoma","volume":"14","author":"Iqbal","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201080_bib39","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-16-1201","article-title":"Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors","volume":"76","author":"Ireland","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201080_bib40","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-18-0900","article-title":"Immunotherapy in Pancreatic Adenocarcinoma: Beyond \u201cCopy\/Paste","volume":"27","author":"Hester","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201080_bib41","article-title":"The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy","volume":"10","author":"Xie","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201080_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060786","article-title":"TRAP1 Chaperones the Metabolic Switch in Cancer","volume":"12","author":"Wengert","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.omton.2025.201080_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215915","article-title":"Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer","volume":"549","author":"Tsai","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2025.201080_bib44","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/71021","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.201080_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2025.201080_bib46","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib47","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2024.05.001","article-title":"Distinct roles of TREM2 in central nervous system cancers and peripheral cancers","volume":"42","author":"Zhong","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib48","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1535-7163.MCT-12-0342","article-title":"Cell intrinsic role of COX-2 in pancreatic cancer development","volume":"11","author":"Hill","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2025.201080_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-4598-4-27","article-title":"Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs","volume":"4","author":"Yoshida","year":"2005","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2025.201080_bib50","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ccell.2021.10.004","article-title":"Capitalizing on the messenger: Intra-tumoral delivery of RNA with a systemic effect","volume":"39","author":"Ott","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib51","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ccell.2024.05.005","article-title":"RNA vaccines for cancer: Principles to practice","volume":"42","author":"Guasp","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201080_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-023-01807-w","article-title":"The use of RNA-based treatments in the field of cancer immunotherapy","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2025.201080_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2025.201080_bib55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ccell.2019.11.007","article-title":"Protein Kinase C\u03b9 and Wnt\/\u03b2-Catenin Signaling: Alternative Pathways to Kras\/Trp53-Driven Lung Adenocarcinoma","volume":"36","author":"Yin","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201080_bib57","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib58","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ymthe.2004.12.021","article-title":"mda-7\/IL24 kills pancreatic cancer cells by inhibition of the Wnt\/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer","volume":"11","author":"Chada","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.201080_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2025.201080_bib60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1158\/2159-8290.CD-21-0922","article-title":"NRF2: KEAPing Tumors Protected","volume":"12","author":"Pillai","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2025.201080_bib62","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2159-8290.CD-23-0486","article-title":"Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer","volume":"14","author":"Murayama","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib63","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1158\/2159-8290.CD-22-1062","article-title":"Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4\u03b1 and Promotes Extrahepatic Carcinogenesis","volume":"13","author":"Goldman","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib64","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","article-title":"CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma","volume":"14","author":"Pal","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib65","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/2159-8290.CD-24-0934","article-title":"PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting","volume":"15","author":"Saxena","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib66","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1158\/2159-8290.CD-24-1196","article-title":"Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines","volume":"14","author":"Berraondo","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201080_bib67","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials on mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omton.2025.201080_bib68","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/gutjnl-2023-330788","article-title":"Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects against pancreatitis in mice","volume":"73","author":"Wang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.omton.2025.201080_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41434-025-00524-x","article-title":"Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application","volume":"32","author":"Mehta","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2025.201080_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.gendis.2023.02.010","article-title":"Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges","volume":"11","author":"Zhao","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.omton.2025.201080_bib71","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1128\/JVI.01304-07","article-title":"Structure of adeno-associated virus serotype 8, a gene therapy vector","volume":"81","author":"Nam","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201080_bib72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature01959","article-title":"The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase","volume":"425","author":"Pintard","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201080_bib73","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.emboj.7600186","article-title":"Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family","volume":"23","author":"Pintard","year":"2004","journal-title":"Embo j"},{"key":"10.1016\/j.omton.2025.201080_bib74","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature01985","article-title":"BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3","volume":"425","author":"Xu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201080_bib75","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/cdd.2011.128","article-title":"TRAP1 and the proteasome regulatory particle TBP7\/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins","volume":"19","author":"Amoroso","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omton.2025.201080_bib76","doi-asserted-by":"crossref","first-page":"20553","DOI":"10.1074\/jbc.M703196200","article-title":"Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis","volume":"282","author":"Hua","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201080_bib77","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-021-03716-6","article-title":"HIF1\u03b1-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia","volume":"12","author":"Laquatra","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201080_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.379","article-title":"Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1","volume":"4","author":"Matassa","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201080_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1335","article-title":"Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2","volume":"9","author":"Patel","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.omton.2025.201080_bib80","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.bbamcr.2015.05.034","article-title":"TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT\/p70S6K pathways","volume":"1853","author":"Agliarulo","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omton.2025.201080_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080580","article-title":"Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy","volume":"8","author":"Torres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2025.201080_bib82","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2019.04.022","article-title":"Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death","volume":"454","author":"Liu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2025.201080_bib83","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omton.2025.201080_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216457","article-title":"A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance","volume":"578","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2025.201080_bib85","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/1541-7786.MCR-08-0365","article-title":"Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells","volume":"7","author":"Li","year":"2009","journal-title":"Mol. Cancer Res."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:21:52Z","timestamp":1772155312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2950329925001493"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201080","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201080"}}